New Key Statistics Module, Z-Score and F-Score
NAS:LXRX Key Ratios
| Market Cap $ M | 279.58 |
| Enterprise Value $ M | 122.41 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.57 |
| Price/Sales | 42.97 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 5.00 |
| EPS (TTM) $ | -0.75 |
| Beneish M-Score | 5.36 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.61 |
| EV-to-EBITDA | -0.62 |
| PEG | -- |
| Shares Outstanding M | 361.49 |
| Net Margin (%) | -4,138.33 |
| Operating Margin % | -4,037.43 |
| Pre-tax Margin (%) | -4,138.33 |
| Quick Ratio | 7.43 |
| Current Ratio | 7.45 |
| ROA % (ttm) | -66.89 |
| ROE % (ttm) | -115.11 |
| ROIC % (ttm) | -333.79 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.42 |
LXRX Number of Guru Trades
LXRX Volume of Guru Trades
Gurus Latest Trades with NAS:LXRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LXRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lexicon Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:LXRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers